1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Spinal Muscular Atrophy Type 3: new trials by email Literature Review of Spinal Muscular Atrophy Type 3 trials Research Report on Spinal Muscular Atrophy Type 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients GC101 - Spinal Muscular Atrophy Type 3 | Phase 1 / Phase 2 | Recruiting | GeneCradle Inc | 21 | 2024-05-10 | 2026-11-17 |
Spinal Muscular Atrophies of Childhood (1)
Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Motor Neuron Disease (1) · Muscular Atrophy, Spinal (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Spinal Cord Diseases (1)
GeneCradle Inc (1)
China (1)